Methods of Treating Testosterone Deficiency
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,564,933 | Methods of Treating Testosterone Deficiency In force · High confidence | Tolmar, Inc. | In force | High confidence | ||
| US 12,605,391 | Methods of Treating Testosterone Deficiency In force · High confidence | Tolmar, Inc. | In force | High confidence | ||
| Application 18/171,790 | Methods of Treating Testosterone Deficiency Abandoned Abandoned May 14, 2024 | Tolmar, Inc. | Abandoned | Abandoned May 14, 2024 |
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Tolmar, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.